Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.
Cho CC, Li SG, Lalonde TJ, Yang KS, Yu G, Qiao Y, Xu S, Ray Liu W. Cho CC, et al. Among authors: yu g. ChemMedChem. 2022 Jan 5;17(1):e202100455. doi: 10.1002/cmdc.202100455. Epub 2021 Oct 12. ChemMedChem. 2022. PMID: 34423563 Free PMC article.
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals.
Alugubelli YR, Geng ZZ, Yang KS, Shaabani N, Khatua K, Ma XR, Vatansever EC, Cho CC, Ma Y, Xiao J, Blankenship LR, Yu G, Sankaran B, Li P, Allen R, Ji H, Xu S, Liu WR. Alugubelli YR, et al. Among authors: yu g. Eur J Med Chem. 2022 Oct 5;240:114596. doi: 10.1016/j.ejmech.2022.114596. Epub 2022 Jul 8. Eur J Med Chem. 2022. PMID: 35839690 Free PMC article.
Expressed Protein Ligation without Intein.
Qiao Y, Yu G, Kratch KC, Wang XA, Wang WW, Leeuwon SZ, Xu S, Morse JS, Liu WR. Qiao Y, et al. Among authors: yu g. J Am Chem Soc. 2020 Apr 15;142(15):7047-7054. doi: 10.1021/jacs.0c00252. Epub 2020 Apr 2. J Am Chem Soc. 2020. PMID: 32212692 Free PMC article.
Corrigendum: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.
Cho CC, Li SG, Lalonde TJ, Yang KS, Yu G, Qiao Y, Xu S, Liu WR. Cho CC, et al. Among authors: yu g. ChemMedChem. 2022 Mar 4;17(5):e202200053. doi: 10.1002/cmdc.202200053. Epub 2022 Feb 8. ChemMedChem. 2022. PMID: 35132799 Free PMC article. No abstract available.
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.
Ren Z, Shao G, Shen J, Zhang L, Zhu X, Fang W, Sun G, Bai Y, Wu J, Liu L, Yuan Y, Zhang J, Li Z, Zhang L, Yin T, Wu J, Hou X, Yu H, Li J, Wang Q, Zhu J, Fan J; Serplulimab-HCC Investigators. Ren Z, et al. Cancer Immunol Immunother. 2025 Jan 3;74(2):69. doi: 10.1007/s00262-024-03917-w. Cancer Immunol Immunother. 2025. PMID: 39751879 Clinical Trial.
Basic Science and Pathogenesis.
Wang E, Wang M, Yu G, Thorpe A, Haroutunian V, Zhang B. Wang E, et al. Among authors: yu g. Alzheimers Dement. 2024 Dec;20 Suppl 1:e089178. doi: 10.1002/alz.089178. Alzheimers Dement. 2024. PMID: 39751531
10,128 results
You have reached the last available page of results. Please see the User Guide for more information.